Immunocytochemistry is now established in many histology laboratories for diagnostic purposes and is routinely used in ascribing an origin to poorly differentiated tumours. This raises the question of whether traditional morphological skills are being abandoned in favour of new technology and, if so, whether that is justified. Twenty-three lymph node biopsies diagnosed as anaplastic carcinoma, reticulosarcoma or unclassifiable tumour between 1940 and 1960 (when immunocytochemistry was not available) were retrieved from the archives of the Radcliffe Infirmary. Paraffin sections were stained with a panel of monoclonal antibodies previously shown to be useful in the identification of tumours of uncertain origin. Of the 15 cases given a definite morphological diagnosis six (40%) were shown to be incorrect on the basis of immunostaining. In the eight remaining cases in which no diagnosis was recorded immunostaining provided a clear diagnosis in seven instances. These results are similar to those recorded on contemporary cases and demonstrate the value of immunocytochemical staining, as an adjunct to traditional morphological examination. In addition, it is clear that currently available monoclonal antibodies are suitable for use on routinely processed material more than 30 years old.

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428198909042460DOI Listing

Publication Analysis

Top Keywords

anaplastic tumours
8
1940 1960
8
1960 immunocytochemistry
8
traditional morphological
8
monoclonal antibodies
8
immunocytochemistry differentiating
4
differentiating high-grade
4
high-grade lymphoma
4
lymphoma anaplastic
4
tumours
4

Similar Publications

Background: Primary squamous cell carcinoma of the thyroid (PSCCT) has recently been reclassified as a morphologic pattern of anaplastic thyroid carcinoma (ATC). Consequently, PSCCT and squamous cell carcinoma with papillary thyroid carcinoma (SCC-PTC) were categorized as ATC. However, in terms of clinical characteristics and overall prognosis, whether PSCCT is similar to SCC-PTC has yet to be sufficiently investigated.

View Article and Find Full Text PDF

Primary cutaneous anaplastic large cell lymphoma (ALCL) is a very uncommon type of CD30-positive T-cell lymphoma, and it very rarely affects the forehead. We report the case of a 68-year-old male presenting with an ulcerative lesion on the right forehead, initially suspected as a benign condition. Fine needle aspiration suggested a lymphoproliferative disorder, with biopsy and immunohistochemistry confirming primary cutaneous ALCL (CD30-positive, anaplastic lymphoma kinase [ALK]-negative).

View Article and Find Full Text PDF

Anaplastic thyroid carcinoma (ATC) is one rare type of thyroid carcinoma without standard systemic treatment for advanced disease. Recent evidence has demonstrated promising efficacy of immune checkpoint inhibitors, particularly those targeting programmed death-1 (PD-1)/programmed death ligand 1 (PD-L1), in a variety of solid tumors. However, there have been no research of immune checkpoint inhibitors plus chemotherapy in ATC.

View Article and Find Full Text PDF

Background: Airway obstruction secondary to chyle leak is an exceptionally rare phenomenon. Here, we describe this complication in a patient with anaplastic thyroid carcinoma (ATC) undergoing consolidative surgery after BRAF-targeted therapy.

Methods: A 55-year-old man presented with a rapidly enlarging neck mass.

View Article and Find Full Text PDF

Introduction: While most thyroid cancer patients have a favorable prognosis, anaplastic thyroid carcinoma (ATC) remains a particularly aggressive form with a median survival time of just five months. Conventional therapies offer limited benefits for this type of thyroid cancer. Our study aims to identify ATC patients who might bene t from immunotherapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!